Asthma Trial, Recruiting NCT07381790 Sponsor: Helse Møre og Romsdal HF Condition: Asthma
Back to Asthma

Asthma Trial, Recruiting

NCT07381790
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a lower respiratory tract infection (an infection affecting the lungs or airways)
  • People who are breathing faster than normal (tachypnea)
  • People who have a wheezing sound when breathing
  • People who are showing visible effort when breathing, such as the muscles around the chest pulling in (retractions)
  • People who are experiencing breathing difficulties

Who may not be able to join:

  • People with a serious heart defect present from birth (certain minor heart defects such as small holes between heart chambers or a specific vessel abnormality may still be considered — confirm with trial site)
  • People with cystic fibrosis or primary ciliary dyskinesia (a condition affecting tiny hair-like structures in the airways)
  • People with muscle or nerve diseases, or other conditions that make it harder to clear the airways
  • People with severe airway softness/weakness (called severe malacia), confirmed by a camera examination of the airways before the start of the trial
  • People who have inhaled a foreign object into their airway
  • People with a collapsed lung (pneumothorax)
  • People with fluid around the lung that requires a medical procedure to treat
  • People who were born very prematurely (before 32 weeks of pregnancy) or who have a chronic lung condition related to premature birth (bronchopulmonary dysplasia)
  • People whose caregiver is not able to communicate in Norwegian or English
  • People who weigh less than 3 kilograms

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4770105000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Helse Møre og Romsdal HF
Registry
ClinicalTrials.gov
Start date
15 December 2025
Est. completion
30 June 2029

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Number of readmissions at 1 year follow-up after baseline.; Length of stay at hospital due to LRTI.; Duration of symptoms after hospitalization due to LRTI.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov